Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cell membrane Lipid-anchor Cytoplasmic side Cytoplasm, perinuclear region Nucleus |
Domain |
PF00071 Ras family |
Function |
Small GTPase. Negatively regulates the transcription regulation activity of the APBB1/FE65-APP complex via its interaction with APBB1/FE65 (By similarity). |
Biological Process |
GO:0007263 nitric oxide mediated signal transduction GO:0019932 second-messenger-mediated signaling |
Molecular Function |
GO:0003924 GTPase activity GO:0005525 GTP binding GO:0019001 guanyl nucleotide binding GO:0032561 guanyl ribonucleotide binding |
Cellular Component |
GO:0016528 sarcoplasm GO:0016529 sarcoplasmic reticulum |
KEGG |
hsa04713 Circadian entrainment |
Reactome | - |
Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between RASD1 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of RASD1 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of RASD1 in various data sets.
|
There is no record. |
Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of RASD1. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of RASD1. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by RASD1. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of RASD1. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of RASD1 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between RASD1 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | RASD1 |
Name | RAS, dexamethasone-induced 1 |
Aliases | DEXRAS1; ras-related protein; dexamethasone-induced ras-related protein 1; activator of G protein signaling; ...... |
Chromosomal Location | 17p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting RASD1 collected from DrugBank database. |
There is no record. |